2015
DOI: 10.1016/j.ctim.2015.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Chinese herbal medicine on health-related quality of life (SF-36) in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…However, preliminary surveys revealed that there was an absence of studies on the anti-inflammatory effects of CHM in PWH to enable a systematic review or meta-analyses to be performed to address this question. Most current meta-analyses either focused on CHM for the treatment of AIDS ( 60 ) or investigated the effects of CHM with or without co-interventions on CVD management, but their favorable outcomes were blood lipid profiles ( 61 ), quality of life ( 62 ) or other specific parameters of the investigated conditions (e.g., blood pressure) ( 63 ), and not inflammatory biomarkers. The available studies were not sufficient to conduct a systematic review: only two RCTs and one parallel controlled study were returned after a comprehensive search of English and Chinese databases.…”
Section: Discussionmentioning
confidence: 99%
“…However, preliminary surveys revealed that there was an absence of studies on the anti-inflammatory effects of CHM in PWH to enable a systematic review or meta-analyses to be performed to address this question. Most current meta-analyses either focused on CHM for the treatment of AIDS ( 60 ) or investigated the effects of CHM with or without co-interventions on CVD management, but their favorable outcomes were blood lipid profiles ( 61 ), quality of life ( 62 ) or other specific parameters of the investigated conditions (e.g., blood pressure) ( 63 ), and not inflammatory biomarkers. The available studies were not sufficient to conduct a systematic review: only two RCTs and one parallel controlled study were returned after a comprehensive search of English and Chinese databases.…”
Section: Discussionmentioning
confidence: 99%
“…Quality of life (QOL) assessment is an important indicator of health status and the effectiveness of intervention measures. The Short Form Health Survey (SF‐36) is widely used to evaluate QOL of hypertension [ 27 ], but symptoms and side effects specific to hypertension are not included. Quality of Life Instruments for Chronic Diseases (QLICD) were developed and validated by Wan [ 15 ] by combining the general module (QLICD‐GM) with the specific module for hypertension.…”
Section: Discussionmentioning
confidence: 99%